Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Gα 14 Inhibitors

Gα14 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the Gα14 protein, which is a member of the Gq family of heterotrimeric G proteins. G proteins play an essential role in cellular signal transduction by acting as molecular switches that relay signals from cell surface receptors, such as G-protein-coupled receptors (GPCRs), to intracellular signaling pathways. Gα14, in particular, is involved in transmitting signals from activated GPCRs to downstream effectors, typically activating phospholipase C (PLC) to induce the production of second messengers like inositol trisphosphate (IP3) and diacylglycerol (DAG). These second messengers regulate various cellular processes, including calcium signaling and protein kinase activation. Inhibitors of Gα14 interfere with its ability to propagate these signals, leading to a disruption in the signaling cascade it controls.

The Gα14 protein itself is part of a larger family of Gα subunits that differ in their specific interactions with receptors and effectors. Gα14 is predominantly expressed in certain tissues, such as the liver, kidney, and spleen, and is involved in mediating tissue-specific signaling pathways. When Gα14 is activated by GPCRs, it exchanges GDP for GTP, leading to the activation of downstream targets like PLC. Inhibition of Gα14 prevents this activation, effectively blocking the signal transduction that would normally follow receptor activation. By studying Gα14 inhibitors, researchers can gain insights into the precise role of Gα14 in cellular signaling networks, the modulation of second messenger pathways, and how these processes contribute to the regulation of cellular function. These inhibitors are critical tools for exploring the complexity of G protein signaling and the specific contributions of different Gα subunits.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

YM 254890

568580-02-9sc-507356
1 mg
$510.00
(0)

YM-254890 is a selective inhibitor of Gαq/11, which could indirectly influence Gα14-associated signaling pathways by modulating GPCR signaling.

FR 900359

107530-18-7sc-507357
500 µg
$226.00
(0)

UBO-QIC, also known as FR900359, is a potent inhibitor of Gαq family proteins, potentially affecting pathways that intersect with Gα14 signaling.

Suramin sodium

129-46-4sc-507209
sc-507209F
sc-507209A
sc-507209B
sc-507209C
sc-507209D
sc-507209E
50 mg
100 mg
250 mg
1 g
10 g
25 g
50 g
$152.00
$214.00
$728.00
$2601.00
$10965.00
$21838.00
$41096.00
5
(1)

Suramin is a GPCR antagonist that can modulate several signaling pathways, potentially influencing Gα14 function indirectly.

Pertussis Toxin (islet-activating protein)

70323-44-3sc-200837
50 µg
$451.00
3
(1)

Pertussis Toxin inhibits Gi/o proteins. While it doesn't directly target Gα14, its modulation of GPCR pathways might have indirect effects on Gα14 signaling.

NF449

627034-85-9sc-478179
sc-478179A
sc-478179B
10 mg
25 mg
100 mg
$203.00
$469.00
$1509.00
1
(0)

NF449 is a potent antagonist of the Gsα subunit of G proteins; it may indirectly affect Gα14 through crosstalk within GPCR signaling networks.

SQ 22536

17318-31-9sc-201572
sc-201572A
5 mg
25 mg
$95.00
$363.00
13
(1)

SQ22536 is an adenylate cyclase inhibitor, impacting cAMP levels and potentially influencing signaling pathways related to Gα14.

KT 5720

108068-98-0sc-3538
sc-3538A
sc-3538B
50 µg
100 µg
500 µg
$138.00
$220.00
$972.00
47
(2)

KT5720 is a protein kinase A (PKA) inhibitor, which might indirectly impact Gα14 signaling by altering downstream effects of GPCR activation.